Cell adhesion and EGFR activation regulate EphA2 expression in cancer.

[1]  Yangde Zhang,et al.  Overexpression of EphA2, MMP‐9, and MVD‐CD34 in hepatocellular carcinoma: Implications for tumor progression and prognosis , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

[2]  E. Haura,et al.  Src kinases as therapeutic targets for cancer , 2009, Nature Reviews Clinical Oncology.

[3]  Elena B Pasquale.  Journal club. A biologist is gratified to find reconciliation for a conflicted receptor. , 2009, Nature.

[4]  E. Pasquale,et al.  Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor. , 2009, The Biochemical journal.

[5]  Jennifer L. Cutter,et al.  EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. , 2009, Cancer cell.

[6]  W. Debinski,et al.  Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor , 2008, Oncogene.

[7]  Hui Wang,et al.  RNA interference targeting EphA2 inhibits proliferation, induces apoptosis, and cooperates with cytotoxic drugs in human glioma cells. , 2008, Surgical neurology.

[8]  W. Debinski,et al.  The EphA2 Receptor and EphrinA1 Ligand in Solid Tumors: Function and Therapeutic Targeting , 2008, Molecular Cancer Research.

[9]  D. Pehlivan,et al.  Involvement of EphA2 in head and neck squamous cell carcinoma: mRNA expression, loss of heterozygosity and immunohistochemical studies. , 2008, Oncology reports.

[10]  Elena B Pasquale,et al.  Eph-Ephrin Bidirectional Signaling in Physiology and Disease , 2008, Cell.

[11]  Guoqi Zhang,et al.  EphA2 is an essential mediator of UV radiation-induced apoptosis. , 2008, Cancer research.

[12]  Dana M. Brantley-Sieders,et al.  The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling. , 2008, The Journal of clinical investigation.

[13]  Hans Skovgaard Poulsen,et al.  Mechanisms for oncogenic activation of the epidermal growth factor receptor. , 2007, Cellular signalling.

[14]  B. Deurs,et al.  Activation of the EGFR Gene Target EphA2 Inhibits Epidermal Growth Factor–Induced Cancer Cell Motility , 2007, Molecular Cancer Research.

[15]  Jin Chen,et al.  Regulation of EphA2 Receptor Endocytosis by SHIP2 Lipid Phosphatase via Phosphatidylinositol 3-Kinase-dependent Rac1 Activation* , 2007, Journal of Biological Chemistry.

[16]  M. Breslin,et al.  The insulinoma-associated 1: a novel promoter for targeted cancer gene therapy for small-cell lung cancer , 2006, Cancer Gene Therapy.

[17]  Liang Cheng,et al.  Expression of EphA2 and Ephrin A-1 in Carcinoma of the Urinary Bladder , 2006, Clinical Cancer Research.

[18]  J. Nesland,et al.  The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas. , 2005, Gynecologic oncology.

[19]  Dana M. Brantley-Sieders,et al.  Impaired tumor microenvironment in EphA2‐deficient mice inhibits tumor angiogenesis and metastatic progression , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  W. Debinski,et al.  EphA2 as a Novel Molecular Marker and Target in Glioblastoma Multiforme , 2005, Molecular Cancer Research.

[21]  N. Pedersen,et al.  Analysis of the epidermal growth factor receptor specific transcriptome: Effect of receptor expression level and an activating mutation , 2005, Journal of cellular biochemistry.

[22]  R. Neve,et al.  A conditional feedback loop regulates Ras activity through EphA2. , 2005, Cancer cell.

[23]  J. Guan,et al.  Inhibition of Integrin-mediated Cell Adhesion but Not Directional Cell Migration Requires Catalytic Activity of EphB3 Receptor Tyrosine Kinase , 2005, Journal of Biological Chemistry.

[24]  Lu‐Hai Wang.  Molecular signaling regulating anchorage-independent growth of cancer cells. , 2004, The Mount Sinai journal of medicine, New York.

[25]  M. Kinch,et al.  EphA2 induction of fibronectin creates a permissive microenvironment for malignant cells. , 2004, Molecular cancer research : MCR.

[26]  V. Rao,et al.  Epidermal Growth Factor Receptor-Dependent Regulation of Integrin-Mediated Signaling and Cell Cycle Entry in Epithelial Cells , 2004, Molecular and Cellular Biology.

[27]  J. Nesland,et al.  PROGNOSTIC VALUE OF EPHA2 AND EPHRINA-1 IN SQUAMOUS CELL CERVICAL CARCINOMA , 2004, International Journal of Gynecologic Cancer.

[28]  N. Pedersen,et al.  Transcriptional gene expression profiling of small cell lung cancer cells. , 2003, Cancer research.

[29]  H. Kuwano,et al.  EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma , 2003, International journal of cancer.

[30]  D. Harpole,et al.  Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[31]  M. Kinch,et al.  Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade , 2002, Oncogene.

[32]  C. Tacchetti,et al.  Integrin-induced Epidermal Growth Factor (EGF) Receptor Activation Requires c-Src and p130Cas and Leads to Phosphorylation of Specific EGF Receptor Tyrosines* , 2002, The Journal of Biological Chemistry.

[33]  Michael Dohn,et al.  Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosis , 2001, Oncogene.

[34]  M. Kinch,et al.  EphA2 overexpression causes tumorigenesis of mammary epithelial cells. , 2001, Cancer research.

[35]  E. Pasquale,et al.  The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization , 2000, Oncogene.

[36]  E. Pasquale,et al.  Eph receptors and ephrin ligands: embryogenesis to tumorigenesis , 2000, Oncogene.

[37]  D. Bennett,et al.  Protein tyrosine kinases in malignant melanoma. , 2000, Melanoma research.

[38]  M. Kinch,et al.  Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation , 2000, Nature Cell Biology.

[39]  D. Bostwick,et al.  Overexpression of the EphA2 tyrosine kinase in prostate cancer , 1999, The Prostate.

[40]  M. Maa,et al.  c-Src-mediated Phosphorylation of the Epidermal Growth Factor Receptor on Tyr845 and Tyr1101 Is Associated with Modulation of Receptor Function* , 1999, The Journal of Biological Chemistry.

[41]  L. Silengo,et al.  Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion‐dependent cell survival , 1998, The EMBO journal.

[42]  L. de Leij,et al.  Characterization of three small cell lung cancer cell lines established from one patient during longitudinal follow-up. , 1988, Cancer research.

[43]  G. Bepler,et al.  Establishment and identification of small cell lung cancer cell lines having classic and variant features. , 1985, Cancer research.

[44]  G. Sorenson,et al.  Isolation and growth characteristics of continuous cell lines from small‐cell carcinoma of the lung , 1980, Cancer.

[45]  G. Bepler,et al.  Establishment, growth properties, and morphological characteristics of permanent human small cell lung cancer cell lines , 2004, Journal of Cancer Research and Clinical Oncology.